AR078370A1 - Combinacion y composicion que contiene un antimicrobiano, un glucocorticoide y un antimicotico - Google Patents
Combinacion y composicion que contiene un antimicrobiano, un glucocorticoide y un antimicoticoInfo
- Publication number
- AR078370A1 AR078370A1 ARP100103350A ARP100103350A AR078370A1 AR 078370 A1 AR078370 A1 AR 078370A1 AR P100103350 A ARP100103350 A AR P100103350A AR P100103350 A ARP100103350 A AR P100103350A AR 078370 A1 AR078370 A1 AR 078370A1
- Authority
- AR
- Argentina
- Prior art keywords
- glucocorticoid
- antimicrobial
- combination
- antimicotic
- composition containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Una composicion farmacéutica topica que comprende la combinacion de un antimicrobiano como por ejemplo ácido fusídico, un glucocorticoide como por ejemplo valerato y/o propionato de betametasona, un antimicotico como por ejemplo clotrimazol, imidazol, ketoconazol, miconazol o tionazol y mezclas de los mismos, y vehículos o excipientes farmacéuticamente aceptables; el proceso de fabricacion de la composicion y el uso de dicha composicion para tratamiento de padecimientos localizados de dermatosis.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MX2009009884A MX2009009884A (es) | 2009-09-15 | 2009-09-15 | Combinacion y composicion que contiene un antimicrobiano, un glucocorticoide y un antimicotico. |
Publications (1)
Publication Number | Publication Date |
---|---|
AR078370A1 true AR078370A1 (es) | 2011-11-02 |
Family
ID=43759111
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP100103350A AR078370A1 (es) | 2009-09-15 | 2010-09-14 | Combinacion y composicion que contiene un antimicrobiano, un glucocorticoide y un antimicotico |
Country Status (15)
Country | Link |
---|---|
US (1) | US8895538B2 (es) |
EP (1) | EP2478908B1 (es) |
AR (1) | AR078370A1 (es) |
BR (1) | BR112012005895B8 (es) |
CA (1) | CA2774356C (es) |
CO (1) | CO6511242A2 (es) |
CR (1) | CR20120114A (es) |
DO (1) | DOP2012000065A (es) |
EC (1) | ECSP12011727A (es) |
ES (1) | ES2716505T3 (es) |
GT (1) | GT201200074A (es) |
HN (1) | HN2012000527A (es) |
MX (1) | MX2009009884A (es) |
PE (1) | PE20121351A1 (es) |
WO (1) | WO2011033361A2 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105687206A (zh) * | 2014-11-27 | 2016-06-22 | 四川海思科制药有限公司 | 一种夫西地酸戊酸倍他米松乳膏药物组合物及其制备方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4298604B1 (en) | 1980-10-06 | 1998-12-22 | Schering Corp | Clotrimazole-betamethasone dipropionate combination |
US6656928B1 (en) * | 1999-09-02 | 2003-12-02 | Mccadden Michael E. | Composition for the topical treatment of rashes, dermatoses and lesions |
RU2470645C2 (ru) * | 2007-09-10 | 2012-12-27 | Гленмарк Фармасьютикалс Лимитед | Фармацевтическая композиция для местного применения, содержащая комбинацию фузидовой кислоты и кортикостероида |
WO2010106465A1 (en) | 2009-03-17 | 2010-09-23 | Sulur Subramaniam Vanangamudi | A dermaceutical cream made using sodium fusidate, clotrimazole and fluticasone propionate |
US20120035144A1 (en) | 2009-04-20 | 2012-02-09 | Apex Laboratories Private Limited | Medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, a corticosteroid, and an antifungal agent, and a process to make it. |
WO2010122475A1 (en) | 2009-04-20 | 2010-10-28 | Sulur Subramaniam Vanangamudi | A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, clotrimazole and mometasone, and a process to make it |
-
2009
- 2009-09-15 MX MX2009009884A patent/MX2009009884A/es active IP Right Grant
-
2010
- 2010-09-14 ES ES10816763T patent/ES2716505T3/es active Active
- 2010-09-14 WO PCT/IB2010/002301 patent/WO2011033361A2/es active Application Filing
- 2010-09-14 EP EP10816763.6A patent/EP2478908B1/en not_active Not-in-force
- 2010-09-14 US US13/496,164 patent/US8895538B2/en not_active Expired - Fee Related
- 2010-09-14 BR BR112012005895A patent/BR112012005895B8/pt not_active IP Right Cessation
- 2010-09-14 AR ARP100103350A patent/AR078370A1/es unknown
- 2010-09-14 PE PE2012000327A patent/PE20121351A1/es active IP Right Grant
- 2010-09-14 CA CA2774356A patent/CA2774356C/en not_active Expired - Fee Related
-
2012
- 2012-03-12 EC ECSP12011727 patent/ECSP12011727A/es unknown
- 2012-03-12 CR CR20120114A patent/CR20120114A/es unknown
- 2012-03-13 HN HN2012000527A patent/HN2012000527A/es unknown
- 2012-03-13 DO DO2012000065A patent/DOP2012000065A/es unknown
- 2012-03-14 CO CO12044629A patent/CO6511242A2/es unknown
- 2012-03-15 GT GT201200074A patent/GT201200074A/es unknown
Also Published As
Publication number | Publication date |
---|---|
BR112012005895B8 (pt) | 2021-05-25 |
EP2478908A4 (en) | 2013-04-03 |
CR20120114A (es) | 2012-06-08 |
ECSP12011727A (es) | 2012-04-30 |
GT201200074A (es) | 2014-03-05 |
DOP2012000065A (es) | 2012-05-31 |
HN2012000527A (es) | 2014-09-22 |
US8895538B2 (en) | 2014-11-25 |
EP2478908A2 (en) | 2012-07-25 |
MX2009009884A (es) | 2011-03-16 |
EP2478908B1 (en) | 2018-12-26 |
WO2011033361A3 (es) | 2011-07-21 |
US20120178727A1 (en) | 2012-07-12 |
CO6511242A2 (es) | 2012-08-31 |
CA2774356C (en) | 2017-05-30 |
PE20121351A1 (es) | 2012-10-27 |
BR112012005895B1 (pt) | 2020-11-24 |
ES2716505T3 (es) | 2019-06-12 |
WO2011033361A2 (es) | 2011-03-24 |
CA2774356A1 (en) | 2011-03-24 |
BR112012005895A2 (pt) | 2017-06-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Sahni et al. | Newer topical treatments in skin and nail dermatophyte infections | |
DOP2022000124A (es) | Derivados de pirazolilo útiles como agentes anticancerígenos | |
PH12018501807A1 (en) | Pyrazolopyrrolidine derivatives and their use in the treatment of diseas | |
UY30559A1 (es) | Derivados de morfolino pirimidina, procesos de preparacion, composiciones conteniéndolos y aplicaciones | |
DOP2010000011A (es) | Derivados de pirimidina trisustituida para el tratamiento de enfermedades proliferativas | |
UY30759A1 (es) | Compuestos quimicos | |
CR11199A (es) | Derivados de pirimidina trisustituida para el tratamiento de enfermedades proliferativas | |
MA32562B1 (fr) | Composes organiques pour la cicatrisation de lesion | |
GT200900328A (es) | Derivados de bencimidazol | |
CR11641A (es) | Derivados heterociclicos de urea y metodos de uso de los mismos-211 | |
CL2012000754A1 (es) | Compuestos derivados de benzoxazepina condensadas con pirazolilo o imidazolilo, inhibidores de la actividad de la quinasa pi3; composicion farmaceutica que comprende un compuesto; y su uso en la preparacion de medicamentos para el tratamiento del cancer. | |
CL2007002994A1 (es) | Compuestos derivados heterociclicos que contienen sulfamoilo, inhibidores de hsp90; composicion farmaceutica; y uso para el tratamiento del cancer, tal como cancer de mama, de colon y prostata, entre otros. | |
TN2013000413A1 (en) | Glycoside derivatives and their uses for the treatment of diabetes | |
UY30544A1 (es) | Compuestos de pirrolo-piperidina y sales farmacéuticametne aceptables de los mismos, procesos de fabricacion, composiciones y aplicaciones | |
ECSP13012698A (es) | Derivados de imidazol como inhibidores de la enzima pde10a | |
WO2007131253A3 (de) | Verwendung von kombinationspräparaten, umfassend antimykotika | |
CR11825A (es) | Derivados de urea heterociclicos para el tratamiento de infecciones bacterianas | |
DOP2010000374A (es) | Derivados heterociclicos de la urea y sus metodos de empleo | |
BR112014004879A2 (pt) | uso de inibidor de aromatase para tratamento de hipogonadismo e doenças relacionadas | |
MX2013011926A (es) | Derivados de glicosido y usos de los mismos. | |
AR078370A1 (es) | Combinacion y composicion que contiene un antimicrobiano, un glucocorticoide y un antimicotico | |
CL2008003062A1 (es) | Compuestos derivados de pirazoles espiro conjugados, inhibidores de la actividad de ksp kinesina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de enfermedades proliferativas. | |
UY33332A (es) | Compuestos de triazol como inhibidores de ksp | |
CO6700886A2 (es) | Derivados de imidazol como inhibidores de la enzima pde10a | |
CO6280050A1 (es) | Forma farmaceutica de inhibidores de la fosfodiesterasa para administracion transmucosa |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |